Back

A Double-blind Randomized Homeopathic Remedy Proving with Healthy Individuals: Comparison of Two High Potencies (C30)

Principal Investigators: H. Möllinger, MD; H. Walach, PhD

Affiliations: Gesundheitszentrum Sokrates, Güttingen, Switzerland; University Hospital Freiburg, Department of Environmental Medicine and Hospital Epidemiology

Background: Homeopathic remedy proving with healthy individuals is one of the basic prerequisites for homeopathic therapy. However, until now there is no evidence that the symptoms elicited in a homeopathic remedy proving actually differ from those of placebo.

Objective of the study: To compare two homeopathic high potencies which previously have not been thoroughly tested, but which may more readily differ in their symptoms when compared to each other than when compared with placebo.

Methods: This homeopathic remedy proving will be prospective, randomized, and double-blind with parallel groups. There will be two groups: Group A (Freiburg group) with physicians trained in homeopathy and experienced with remedy provings, and group B (Swiss group) with physicians trained in homeopathy, but with no or little experience in remedy provings. Randomization will be performed by a supervisor. The two main goals of the study are to determine whether the symptoms tested in the remedy provings are specific for the remedy, and whether the symptoms can be assigned to the two remedies and the placebo, respectively. Symptoms will be analyzed according to the repertory by Kent, the most common tool for symptom analysis in homeopathy. In addition, intensity, frequency, and modalities will be considered.

Relationship to SIIB Mission and Healing: Homeopathy has suffered from a dearth of solidly constructed scientific studies in provings which consisted of randomization and double blinding. This research will contribute to a more thorough and rigorous analysis of the proving process.



 





Funded Research